background

New compounds targeting the pathways critical to end-organ damage and cancer

CCRP Therapeutics is a biopharmaceutical spin-off of Charité's Center for Cardiovascular Research (CCR), supported by the German Federal Ministry of Education and Research (BMBF) under its GO-Bio initiative.

The company's focus is the discovery of Breakthrough drugs in indications with common pathophysiological mechanisms and high unmet medical need. In collaboration with major pharmaceutical companies innovative therapeutic approces will be further advanced and commercialized.
comtact: PD Dr. Heiko Funke-Kaiser
CCRP Therapeutics GmbH i.G. c/o Center for Cardiovascular Research (CCR)
Hessische Strasse 3-4 10115 Berlin Germany
Phone: + 49 (0)30 450 52 53 06